Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02811549 · ClinicalTrials.gov registry record · NA
Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
A NA study of Hearing Loss and Hearing Disorders, sponsored by Advanced Bionics.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT02811549: Completed NA study of Hearing Loss and Hearing Disorders, sponsored by Advanced Bionics.
NCT02811549 is a NA study of Hearing Loss and Hearing Disorders that has completed, run by Advanced Bionics. The registered enrollment target is 24 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02811549, a NA study of Hearing Loss and Hearing Disorders, has completed, sponsored by Advanced Bionics.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).
Primary Outcome
The post-implant CNC word scores were compared to preimplant word scores. The CNC monosyllabic word test is a validated test of open-set word recognition ability. The test was administered in quiet at 60 target 0° azimuth) and scored as total number of words correct which is expressed for results/reporting as percentage correct. The CNC word test was the primary speech perception metric used for study inclusion determination and postoperative outcome comparison at defined intervals for this feas
Conditions Studied
Interventions
- DEVICE HiResolution Bionic Cochlear Implant
Study Locations (2)
Florida
- The Silverstein Institute - Sarasota
Washington
- Virginia Mason Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-11-07 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
What the finished NCT02811549 record still lists
NCT02811549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which HiResolution Bionic Cochlear Implant is the first listed.
NCT02811549 reports a single indexed study location in Florida, Washington.
Frequently Asked Questions
What is clinical trial NCT02811549 about?
NCT02811549 is a clinical study titled "Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss". The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).
What is the current status of trial NCT02811549?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-11-07. Estimated completion is 2020-03-25.
What conditions does trial NCT02811549 study?
This clinical trial studies the following conditions: Hearing Loss, Hearing Disorders, Single Sided Deafness, Ear Diseases, Otorhinolaryngologic Diseases.
What interventions are being tested in trial NCT02811549?
The interventions under investigation include: HiResolution Bionic Cochlear Implant (DEVICE).
Who is sponsoring clinical trial NCT02811549?
This trial is sponsored by Advanced Bionics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02811549 being conducted?
This trial has 2 study locations across Florida, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02811549's enrollment target sits among peer trials
24 53rd of 58 higher than 5 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI